or
forgot password

Pilot Study Of Primary And Secondary Attention-Deficit/Hyperactivity Disorder Among Survivors Of Childhood Cancer


N/A
12 Years
17 Years
Not Enrolling
Both
ADHD, Cancer

Thank you

Trial Information

Pilot Study Of Primary And Secondary Attention-Deficit/Hyperactivity Disorder Among Survivors Of Childhood Cancer


1. This study will investigate the feasibility of assessing symptoms of developmental ADHD
and "secondary ADHD" (S-ADHD) among adolescent survivors of childhood cancer using a
structured diagnostic clinical interview procedure. (S-ADHD describes an acquired
clinical presentation that is consistent with the diagnostic criteria of ADHD).

2. This study will provide preliminary estimates of the rate of occurrence of ADHD/S-ADHD
among adolescent survivors of childhood cancer as compared to the prevalence of
developmental ADHD in the general population.

3. The study will examine the relationship between ADHD/S-ADHD symptoms and laboratory
measures traditionally used to assess specific components of attention (e.g., CPT) in
survivors of childhood cancer.

4. The study will examine the relationship between ADHD/S-ADHD symptoms and smoking
(including intentions, behaviors, and motivators) among adolescent survivors of
childhood cancer.


Inclusion Criteria:



1. Patients treated for acute lymphoblastic leukemia (ALL) OR primary central nervous
system (CNS) tumor.

2. Completed primary treatment at least one year prior to enrollment with no evidence of
active disease.

3. Age 12-17 years inclusive at the time of enrollment.

4. At least one parent/guardian must be present.

5. Participant and parent are able to understand English.

6. Participant and parent are willing and able to provide consent/assent according to
institutional guidelines.

7. Parent/guardian signs consent.

Exclusion Criteria:

1.Significant impairment in intellectual functioning (e.g., full or estimated IQ <70) as
documented in the medical record.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

This study will investigate the feasibility of assessing symptoms of developmental ADHD and "secondary ADHD" (S-ADHD) among adolescent survivors of childhood cancer using a structured diagnostic clinical interview procedure.

Outcome Time Frame:

1 year

Safety Issue:

No

Principal Investigator

Vida L Tyc, Ph.D

Investigator Role:

Principal Investigator

Investigator Affiliation:

St. Jude Children's Research Hospital

Authority:

United States: Institutional Review Board

Study ID:

SADHD1

NCT ID:

NCT01032811

Start Date:

October 2008

Completion Date:

September 2009

Related Keywords:

  • ADHD
  • Cancer
  • ADHD, childhood cancer
  • ADHD/Secondary ADHD Among Survivors of Childhood Cancer
  • Hyperkinesis
  • Attention Deficit Disorder with Hyperactivity

Name

Location
St . Jude Children's Research Hospital Memphis, Tennessee  38105